Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Lower cost strategies for triage of human papillomavirus DNA-positive women.

Qiao YL, Jeronimo J, Zhao FH, Schweizer J, Chen W, Valdez M, Lu P, Zhang X, Kang LN, Bansil P, Paul P, Mahoney C, Berard-Bergery M, Bai P, Peck R, Li J, Chen F, Stoler MH, Castle PE.

Int J Cancer. 2014 Jun 15;134(12):2891-901. doi: 10.1002/ijc.28616. Epub 2013 Dec 3.

2.

An evaluation of novel, lower-cost molecular screening tests for human papillomavirus in rural China.

Zhao FH, Jeronimo J, Qiao YL, Schweizer J, Chen W, Valdez M, Lu P, Zhang X, Kang LN, Bansil P, Paul P, Mahoney C, Berard-Bergery M, Bai P, Peck R, Li J, Chen F, Stoler MH, Castle PE.

Cancer Prev Res (Phila). 2013 Sep;6(9):938-48. doi: 10.1158/1940-6207.CAPR-13-0091. Epub 2013 Jul 22.

3.

Cervical cancers require the continuous expression of the human papillomavirus type 16 E7 oncoprotein even in the presence of the viral E6 oncoprotein.

Jabbar SF, Park S, Schweizer J, Berard-Bergery M, Pitot HC, Lee D, Lambert PF.

Cancer Res. 2012 Aug 15;72(16):4008-16. doi: 10.1158/0008-5472.CAN-11-3085. Epub 2012 Jun 13.

4.

Association of elevated E6 oncoprotein with grade of cervical neoplasia using PDZ interaction-mediated precipitation of E6.

Sellors JW, Schweizer JG, Lu PS, Liu B, Weigl BH, Cui JF, Peck RB, Lewis K, Lim J, Howard M, Mahoney CW, McAllister L, Berard-Bergery M, Bry C, Labiad YA, Li H, Liu L, Silver J, Chen W, Qiao YL.

J Low Genit Tract Dis. 2011 Apr;15(2):169-76. doi: 10.1097/LGT.0b013e3181f6c84d.

PMID:
21478701
5.

Feasibility study of a human papillomavirus E6 oncoprotein test for diagnosis of cervical precancer and cancer.

Schweizer J, Lu PS, Mahoney CW, Berard-Bergery M, Ho M, Ramasamy V, Silver JE, Bisht A, Labiad Y, Peck RB, Lim J, Jeronimo J, Howard R, Gravitt PE, Castle PE.

J Clin Microbiol. 2010 Dec;48(12):4646-8. doi: 10.1128/JCM.01315-10. Epub 2010 Oct 6.

Supplemental Content

Loading ...
Support Center